Inventor

ARVANITIS ARGYRIOS G

US20 patents

⚠️ This page may combine multiple inventors who share the name “ARVANITIS ARGYRIOS G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARVANITIS ARGYRIOS G

RODGERS JAMES D

Cyclohexyl azetidine derivatives as JAK inhibitors

Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

INCYTE CORP

N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

Substituted heterocycles as janus kinase inhibitors

Azepine inhibitors of janus kinases

Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

BRISTOL MYERS SQUIBB CO

Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders

Pyrimidine derivatives as corticotropin releasing factor inhibitors

Pyridinyl derivatives for the treatment of depression

ARVANITIS ARGYRIOS G

Azepine inhibitors of Janus kinases

Substituted heterocycles as Janus kinase inhibitors

BRISTOL MYERS SQUIBB PHARMA CO

Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands

Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands

DU PONT PHARM CO

Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders

DU PONT MERCK PHARMA

Alkyl and alkylbenzyl ethers of substituted hydroquinones